Drug Interactions between guaifenesin / hydrocodone and Levaquin
This report displays the potential drug interactions for the following 2 drugs:
- guaifenesin/hydrocodone
- Levaquin (levofloxacin)
Interactions between your drugs
No interactions were found between guaifenesin / hydrocodone and Levaquin. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
guaifenesin / hydrocodone
A total of 605 drugs are known to interact with guaifenesin / hydrocodone.
- Guaifenesin / hydrocodone is in the drug class upper respiratory combinations.
- Guaifenesin / hydrocodone is used to treat Cough.
Levaquin
A total of 525 drugs are known to interact with Levaquin.
- Levaquin is in the drug class quinolones and fluoroquinolones.
-
Levaquin is used to treat the following conditions:
- Anthrax
- Anthrax Prophylaxis
- Bacterial Infection
- Bladder Infection
- Bronchitis
- Chlamydia Infection
- Epididymitis, Sexually Transmitted
- Gonococcal Infection, Disseminated
- Gonococcal Infection, Uncomplicated
- Kidney Infections
- Middle Ear Infections (off-label)
- Nongonococcal Urethritis
- Nosocomial Pneumonia
- Pelvic Inflammatory Disease
- Plague
- Plague Prophylaxis
- Pneumonia
- Prostatitis
- Sinusitis
- Skin or Soft Tissue Infection
- Streptococcal Infection
- Tuberculosis, Active
- Urinary Tract Infection
Drug and food interactions
HYDROcodone food
Applies to: guaifenesin / hydrocodone
GENERALLY AVOID: Alcohol may potentiate the central nervous system (CNS) depressant effects of opioid analgesics including hydrocodone. Concomitant use may result in additive CNS depression and impairment of judgment, thinking, and psychomotor skills. In more severe cases, hypotension, respiratory depression, profound sedation, coma, or even death may occur.
GENERALLY AVOID: Consumption of alcohol while taking some sustained-release formulations of hydrocodone may cause rapid release of the drug, resulting in high systemic levels of hydrocodone that may be potentially lethal. Alcohol apparently can disrupt the release mechanism of some sustained-release formulations. In study subjects, the rate of absorption of hydrocodone from an extended-release formulation was found to be affected by coadministration with 40% alcohol in the fasted state, as demonstrated by an average 2.4-fold (up to 3.9-fold in one subject) increase in hydrocodone peak plasma concentration and a decrease in the time to peak concentration. Alcohol also increased the extent of absorption by an average of 1.2-fold (up to 1.7-fold in one subject).
GENERALLY AVOID: Grapefruit juice may increase the plasma concentrations of hydrocodone. The proposed mechanism is inhibition of CYP450 3A4-mediated metabolism of hydrocodone by certain compounds present in grapefruit. Increased hydrocodone concentrations could conceivably increase or prolong adverse drug effects and may cause potentially fatal respiratory depression.
MANAGEMENT: Patients taking sustained-release formulations of hydrocodone should not consume alcohol or use medications that contain alcohol. In general, potent narcotics such as hydrocodone should not be combined with alcohol. Patients should also avoid consumption of grapefruit or grapefruit juice during treatment with hydrocodone.
References (1)
- (2013) "Product Information. Zohydro ER (hydrocodone)." Zogenix, Inc
levoFLOXacin food
Applies to: Levaquin (levofloxacin)
ADJUST DOSING INTERVAL: Food may reduce the oral absorption and bioavailability of levofloxacin. According to the drug product labeling, administration of levofloxacin 500 mg with food prolonged the time to peak concentration by 1 hour and decreased the Cmax decreased by 25% following administration of the oral solution and by 14% following administration of the oral tablet.
MANAGEMENT: To ensure maximal and consistent oral absorption, levofloxacin oral solution should be taken at least one hour before or two hours after meals. For administration of the oral solution with continuous enteral nutrition, some experts recommend that the tube feeding should be interrupted for one hour before and two hours after the dose of levofloxacin. The oral tablets may be taken without regard to food.
References (1)
- Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT (2009) "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm, 66, p. 1438-67
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.